How has been the historical performance of Biocon?

Answer:The historical performance of Biocon shows a consistent growth trajectory in net sales and profitability over the years, culminating in the latest figures for March 2025.

Breakdown:
Biocon's net sales have increased significantly from INR 5,514.40 crore in March 2019 to INR 15,261.70 crore in March 2025, reflecting a robust growth trend. Total operating income followed suit, rising from INR 5,514.40 crore in March 2019 to INR 15,261.70 crore in March 2025. The company's operating profit (PBDIT) also demonstrated a positive trend, growing from INR 1,538.10 crore in March 2019 to INR 4,374.50 crore in March 2025, although the operating profit margin (excluding other income) saw a slight decline from 25.27% in March 2019 to 21.04% in March 2025. Profit before tax increased from INR 1,214.00 crore in March 2019 to INR 1,886.60 crore in March 2025, while profit after tax rose from INR 1,001.70 crore to INR 1,429.40 crore in the same period. The company's total assets have expanded from INR 14,075.80 crore in March 2020 to INR 58,539.60 crore in March 2025, indicating strong asset growth. Total liabilities also increased, from INR 14,075.80 crore in March 2020 to INR 58,539.60 crore in March 2025, reflecting the company's expansion strategy. Cash flow from operating activities improved significantly, reaching INR 4,061.00 crore in March 2025, compared to INR 1,283.00 crore in March 2020. Overall, Biocon's financial performance indicates a solid growth trajectory with increasing revenues and profits, despite some fluctuations in margins and liabilities.